Edition:
United States

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

9.95USD
15 Dec 2017
Change (% chg)

$0.11 (+1.12%)
Prev Close
$9.84
Open
$9.90
Day's High
$10.18
Day's Low
$9.80
Volume
221,862
Avg. Vol
65,696
52-wk High
$17.33
52-wk Low
$8.86

Select another date:

Mon, Dec 4 2017

BRIEF-Seres Therapeutics Announces FDA Orphan Drug Designation For SER-287 In Treatment Of Pediatric Ulcerative Colitis

* SERES THERAPEUTICS ANNOUNCES FDA ORPHAN DRUG DESIGNATION FOR SER-287 IN TREATMENT OF PEDIATRIC ULCERATIVE COLITIS

BRIEF-Seres Therapeutics Q2 net loss $28 million

* Seres therapeutics reports second quarter 2017 financial results and provides update on operational progress

BRIEF-Seres Therapeutics appoints Willard Dere to Board of Directors

* Seres Therapeutics strengthens board of directors with appointment of Willard Dere, M.D., former Amgen Chief Medical Officer Source text for Eikon: Further company coverage:

Select another date: